Interprofessional Group Intervention to Promote Faculty Wellbeing and Engagement

March 10, 2020 updated by: Susan Hata, MD, Massachusetts General Hospital
A randomized trial of an interprofessional intervention to reduce burnout and enhance professional engagement in physicians, certified nurse midwives, and nurse practitioners.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

To test the hypothesis that an intervention involving self-facilitated interprofessional group meetings would result in improvement in wellbeing and to determine whether use of a written curriculum provided increased benefit, the following study is conducted:

Practicing clinical faculty in the Department of Obstetrics and Gynecology at the Massachusetts General Hospital were recruited to participate in three monthly small groups over dinner. Participants were randomized to a control group, which met without any specified guidelines for discussion content, or to receive an intervention which consisted of a one-page discussion guide addressing themes relevant to challenges in the healthcare environment: reframing challenging patient interactions; embracing uncertainty in work; and coping with errors, near misses, and bad outcomes. Outcomes included burnout, empowerment and engagement in work, stress from uncertainty assessed using validated metrics, and perception of of collegiality and community.

All participants were also offered the option of participating in evaluation of biomarkers. To test the hypothesis that an increased sense of bonding and relational connection, and reduced stress levels would be reflected by changes in hormone levels during the meeting and over the course of the study. Faculty who opted into this portion of the study gave the following samples:

Urine Oxytocin before and after the first and third group meetings Salivary Oxytocin before and after the first and third group meetings Salivary Cortisol before and after the first and third group meetings Hair Cortisol at the beginning of the study and at the end of the study (a roughly three month interval).

An optional focus group was conducted after the three monthly sessions.

All participants signed a consent form prior to participating in the study.

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02114
        • Massachusetts General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Physican in the Department of Obstetrics and Gynecology at Massachusetts General Hospital
  • Nurse Practitioner in the Department of Obstetrics and Gynecology at Massachusetts General Hospital
  • Certified Nurse Midwife in the Department of Obstetrics and Gynecology at Massachusetts General Hospital

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Providers were placed in small groups and given the intervention of a discussion guide to facilitate discussion.
Written list of prompts to facilitate discussion
No Intervention: Control
Providers were placed in small groups and not given a discussion guide to facilitate discussion.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Burnout
Time Frame: Change over the three month study period. Baseline measurement and immediately after final intervention.

Change from baseline in 2 item Maslach Burnout Inventory scores before and after the intervention.

Minimum score: 2; Maximum score: 14 Higher score = more burnt out (worse outcome)

Change over the three month study period. Baseline measurement and immediately after final intervention.
Stress from Uncertainty
Time Frame: Change over the three month study period. Baseline measurement and immediately after final intervention.
Change in scores on Physician Response to Uncertainty Scale before and after intervention Minimum score: 6; Maximum score: 90 Higher score = increased stress due to uncertainty (worse outcome)
Change over the three month study period. Baseline measurement and immediately after final intervention.
Work Engagement
Time Frame: Change over the three month study period. Baseline measurement and immediately after final intervention.
Change in scores on Utrecht Work Engagement Scale before and after intervention Minimum score: 0; Maximum score: 54 Higher score = higher engagement at work (better outcome)
Change over the three month study period. Baseline measurement and immediately after final intervention.
Urine oxytocin
Time Frame: Two samples were taken one hour apart at baseline, and this was repeated three months later.
Change from baseline in the level of urine oxytocin before and after each intervention. This is an exploratory study so the maximum and minimum values are not known, and any change up or down is interesting.
Two samples were taken one hour apart at baseline, and this was repeated three months later.
Salivary Oxytocin
Time Frame: Two samples were taken one hour apart at baseline, and this was repeated three months later
Change from baseline in the level of salivary oxytocin before and after each intervention. This is an exploratory study so the maximum and minimum values are not known, and any change up or down is interesting.
Two samples were taken one hour apart at baseline, and this was repeated three months later
Salivary Cortisol
Time Frame: Two samples were taken one hour apart at baseline, and this was repeated three months later
Change from baseline in the level of salivary cortisol before and after each intervention. This is an exploratory study so the maximum and minimum values are not known, and any change up or down is interesting.
Two samples were taken one hour apart at baseline, and this was repeated three months later
Hair Cortisol
Time Frame: Change over the three month study period. Baseline measurement and immediately after final intervention.
Change from baseline in hair cortisol levels. Maximum and minimum levels are not known and any change up or down is interesting.
Change over the three month study period. Baseline measurement and immediately after final intervention.
Work Empowerment Scale
Time Frame: Change over the three month study period. Baseline measurement and immediately after final intervention.
Minimum score: 12; Maximum score: 84 Change from baseline on Work Empowerment Scale before and after intervention. Higher score = higher empowerment at work (better outcome)
Change over the three month study period. Baseline measurement and immediately after final intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2018

Primary Completion (Actual)

September 30, 2018

Study Completion (Actual)

September 30, 2018

Study Registration Dates

First Submitted

March 3, 2020

First Submitted That Met QC Criteria

March 10, 2020

First Posted (Actual)

March 12, 2020

Study Record Updates

Last Update Posted (Actual)

March 12, 2020

Last Update Submitted That Met QC Criteria

March 10, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Burnout, Professional

Clinical Trials on Discussion Guide

3
Subscribe